In the Rotterdam Study7, 8, individuals with increasing levels of Lp-PLA2 were associated with an increased risk of developing cognitive impairment over a mean follow-up of 5.7 years and people in the upper quartile had a 56% higher risk compared with those in the lower quartile. Here, PLA2G7 is linked to Cognitive impairment.